Get access

Response of Australian veterinarians to the announcement of a Hendra virus vaccine becoming available

Authors

  • D Mendez,

    Corresponding author
    • Anton Breinl Centre for Public Health and Tropical Medicine, James Cook University, Townsville, Queensland, Australia
    Search for more papers by this author
  • P Büttner,

    1. Anton Breinl Centre for Public Health and Tropical Medicine, James Cook University, Townsville, Queensland, Australia
    2. Tropical Health Solutions Pty Ltd, Townsville, Queensland, Australia
    Search for more papers by this author
  • R Speare

    1. Anton Breinl Centre for Public Health and Tropical Medicine, James Cook University, Townsville, Queensland, Australia
    2. Tropical Health Solutions Pty Ltd, Townsville, Queensland, Australia
    Search for more papers by this author

Corresponding author.

Abstract

Design

A cross-sectional study of private veterinarians providing equine services in Queensland.

Results

The study revealed that a majority of veterinarians would support the introduction of a Hendra virus (HeV) vaccine. Moreover, almost half of the respondents intended to make vaccination a prerequisite to horse patient presentation. However, participants also responded that a vaccine would not reduce the risk sufficiently to cease or downgrade their HeV management plan and infection control measures.

Conclusion

When devising promoting and marketing campaigns, government agencies and manufacturers should consider private veterinarians' intentions as a significant driver for the uptake of the HeV vaccine.

Ancillary